Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AQST - Aquestive avoids potential roadblock to U.S. approval of Libervant


AQST - Aquestive avoids potential roadblock to U.S. approval of Libervant

  • Investors in Aquestive Therapeutics (NASDAQ:AQST) can breathe a bit easier on the potential FDA nod for Libervant (diazepam) Buccal Film for the potential treatment of intermittent stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient’s usual seizure pattern in epilepsy patients at least six years old.
  • More news on: Aquestive Therapeutics, Inc., Healthcare stocks news,
  • Read more ...
Stock Information

Company Name: Aquestive Therapeutics Inc.
Stock Symbol: AQST
Market: NASDAQ
Website: aquestive.com

Menu

AQST AQST Quote AQST Short AQST News AQST Articles AQST Message Board
Get AQST Alerts

News, Short Squeeze, Breakout and More Instantly...